Loading clinical trials...
Loading clinical trials...
Evaluation of ProALL microRNAs in Blood Specimen for Prediction of Acute Lymphoblastic Leukemia Relapse Risk
Conditions
Locations
2
Israel
Rambam Health Care Campus
Haifa, Israel
Schneider Children's Medical Center of Israel
Petah Tikva, Israel
Start Date
December 1, 2016
Primary Completion Date
May 1, 2020
Completion Date
December 1, 2021
Last Updated
February 4, 2019
NCT07429461
NCT06785818
NCT06863259
NCT07223021
NCT05470777
NCT06793241
Lead Sponsor
Curewize Health Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions